3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
13
Pancreatic Neoplasms
6
Breast Neoplasms
6
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Thyroid Diseases
2
Prostatic Neoplasms
2
Pancreatic Cyst
2
Neoplasm Metastasis
2
Myasthenia Gravis
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Wilms Tumor
1
Venous Thrombosis
1
Venous Thromboembolism
1
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thrombosis
1
Testicular Neoplasms
1
Interventions
Etoposide
79
Carboplatin
67
Cisplatin
58
durvalumab
29
Irinotecan
29
Radiotherapy
27
atezolizumab
23
Topotecan
21
anlotinib
19
Nivolumab
15
Drug Therapy
15
Radiosurgery
14
Gemcitabine
13
apatinib
12
Paclitaxel
12
toripalimab
10
Platinum
10
Docetaxel
10
tislelizumab
9
Temozolomide
9
PM 01183
8
pembrolizumab
7
olaparib
7
Magnetic Resonance Spectroscopy
7
Ipilimumab
7
Bevacizumab
7
Albumin-Bound Paclitaxel
7
irinotecan sucrosofate
6
Counseling
6
sintilimab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Small Cell Lung Carcinoma
×
Data Collection
×
Clear all
NCT02622581
2025-02-18
CRISP
AIO-Studien-gGmbH
Recruiting
12,400 enrolled